Details for Patent: 5,292,756
✉ Email this page to a colleague
Summary for Patent: 5,292,756
| Title: | Novel sulfonamide fibrinogen receptor antagonists |
| Abstract: | A series of non-peptide derivatives of the formula ##STR1## that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation. |
| Inventor(s): | Duggan; Mark E. (Narberth, PA), Egbertson; Melissa S. (Ambler, PA), Halczenko; Wasyl (Hatfield, PA), Hartman; George D. (Lansdale, PA) |
| Assignee: | Merck & Co., Inc. (Rahway, NJ) |
| Application Number: | 07/860,747 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent 5,292,756
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,292,756
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0478363 | ⤷ Sign Up | SPC/GB99/042 | United Kingdom | ⤷ Sign Up |
| European Patent Office | 0478363 | ⤷ Sign Up | C990040 | Netherlands | ⤷ Sign Up |
| European Patent Office | 0478363 | ⤷ Sign Up | 2000C/002 | Belgium | ⤷ Sign Up |
| European Patent Office | 0478363 | ⤷ Sign Up | 48/1999 | Austria | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
